PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2102590
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2102590
According to Stratistics MRC, the Global Veterinary Reference Laboratory Market is accounted for $5.8 billion in 2026 and is expected to reach $12.1 billion by 2034 growing at a CAGR of 9.5% during the forecast period. Veterinary reference laboratories are specialized diagnostic facilities that provide advanced testing services for animal health, supporting veterinarians in disease diagnosis, treatment planning, and health monitoring. These laboratories utilize a wide range of technologies including clinical biochemistry analyzers, immunoassay technologies, molecular diagnostic technologies, microbiology technologies, digital pathology, flow cytometry, mass spectrometry, and other diagnostic platforms. Testing is performed on various sample types including blood, serum and plasma, urine, fecal samples, tissue samples, saliva, milk, swab samples, and other biological specimens. Growing pet ownership, increasing demand for advanced diagnostic services, rising prevalence of zoonotic and chronic diseases, and technological advancements in veterinary diagnostics are key drivers of market expansion across all regions.
Increasing pet ownership and demand for advanced diagnostic services
The rising global pet population and growing demand for sophisticated veterinary diagnostic services are primary drivers for the veterinary reference laboratory market. Pet owners increasingly expect advanced diagnostic capabilities comparable to human healthcare, including comprehensive laboratory testing for accurate disease diagnosis and monitoring. The humanization of pets has led to greater investment in preventive and specialty care, driving demand for reference laboratory services. As veterinary practices expand services and referral networks grow, reference laboratory utilization increases. Growing awareness of the benefits of early disease detection through comprehensive testing further supports market growth. These trends across developed and emerging markets sustain strong demand for veterinary reference laboratory services.
High testing costs and limited insurance coverage
The significant costs associated with advanced veterinary diagnostic testing and limited insurance coverage represent a major restraint for the market. Comprehensive reference laboratory testing can be expensive, potentially limiting access for some pet owners. Veterinary insurance coverage varies across regions and may not cover all diagnostic tests. Pet owners may face financial constraints that limit testing utilization. Practices may be reluctant to recommend extensive testing without clear reimbursement pathways. These cost barriers may limit testing volumes, particularly in price-sensitive markets and for less critical conditions.
Technological advancements in veterinary diagnostics
Continuous innovation in diagnostic technologies presents significant opportunities for veterinary reference laboratory market expansion. Molecular diagnostic technologies including PCR and next-generation sequencing are enabling more accurate and rapid disease detection. Digital pathology and AI-assisted diagnostics are improving interpretation accuracy and efficiency. Point-of-care testing advancements are complementing reference laboratory services. Novel biomarker discovery is expanding diagnostic capabilities. Automation and laboratory information systems are improving operational efficiency. As technology advances and becomes more accessible, new testing applications and improved service delivery capture growing market share.
Consolidation of veterinary practices and in-house testing expansion
The trend toward consolidation of veterinary practices into large corporate groups and the expansion of in-house testing capabilities pose significant threats to reference laboratory market growth. Corporate veterinary groups may centralize testing or develop their own laboratory networks, reducing external reference laboratory utilization. Advances in point-of-care and in-house testing equipment enable more comprehensive testing within practices. Some previously reference-only tests are becoming available for in-house use. This trend may limit growth in reference laboratory testing volumes for certain test categories.
The COVID-19 pandemic had a significant impact on the veterinary reference laboratory market. Initial disruptions included reduced veterinary visits during lockdowns and supply chain interruptions. However, pet adoption surged during the pandemic, expanding the patient population. The pandemic highlighted the importance of diagnostic testing for zoonotic disease surveillance. Telemedicine and remote consultation expanded, increasing demand for diagnostic testing services. Reference laboratories adapted operations for safety. Post-pandemic, elevated pet ownership and continued focus on animal health have sustained demand for diagnostic services, with reference laboratories maintaining essential roles in veterinary care.
The Clinical Biochemistry Analyzers segment is expected to be the largest during the forecast period
The Clinical Biochemistry Analyzers segment is expected to account for the largest market share during the forecast period, driven by their essential role in routine diagnostic testing for evaluating organ function, metabolic status, and overall health in animals. Clinical biochemistry testing is among the most frequently ordered laboratory services in veterinary medicine, providing critical information for diagnosis and monitoring. The segment benefits from established technology, high testing volumes, and broad application across all animal species. Continuous automation and efficiency improvements support laboratory operations. With high testing volumes and essential diagnostic role, clinical biochemistry analyzers maintain the largest market share.
The Swab Samples segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Swab Samples segment is predicted to witness the highest growth rate, fueled by increasing infectious disease testing, growing demand for respiratory pathogen detection, and the expansion of molecular diagnostic applications. Swab samples are essential for infectious disease diagnosis in both companion animals and livestock. The segment benefits from growing surveillance for zoonotic and emerging infectious diseases. Increasing demand for rapid molecular testing for respiratory pathogens supports growth. As infectious disease testing expands and molecular diagnostics adoption increases, swab samples deliver the fastest segment growth.
During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, strong spending on veterinary care, and advanced veterinary diagnostic infrastructure. The United States leads regional market growth with substantial investment in veterinary reference laboratories and diagnostic services. High awareness of advanced diagnostic options among pet owners supports demand. Strong presence of veterinary diagnostic companies and technology innovation drives adoption. Established referral networks and specialty practices create consistent demand. With high pet spending and advanced diagnostic infrastructure, North America maintains its dominant market position.
Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising pet ownership, expanding veterinary healthcare infrastructure, and increasing awareness of advanced diagnostic services across countries including China, India, Australia, and Southeast Asia. The region's rapidly growing pet population and expanding middle class create substantial demand for veterinary diagnostic services. Veterinary practice modernization and technology adoption are accelerating. Increasing investment in veterinary laboratory infrastructure and specialist training is expanding service availability. Growing awareness of diagnostic testing benefits and increasing insurance coverage support market expansion. As veterinary healthcare develops, Asia Pacific delivers the fastest veterinary reference laboratory market growth globally.
Key players in the market
Some of the key players in Veterinary Reference Laboratory Market include IDEXX Laboratories, Inc., Antech Diagnostics, Zoetis Inc., Mars Incorporated, Heska Corporation, Neogen Corporation, Virbac S.A., Randox Laboratories Ltd., MiDOG Animal Diagnostics, National Veterinary Services Laboratories, Vetnostics, Gribbles Veterinary, NationWide Laboratories, Finn Pathologists, Biobest Laboratories, Animal Health Diagnostic Center, University of California, Davis Veterinary Medical Teaching Hospital, and Texas A&M Veterinary Medical Diagnostic Laboratory.
In May 2026, IDEXX expanded its reference laboratory and point-of-care Fecal Dx(R) antigen testing platform with the global commercial launch of Taeniid Tapeworm Detection, enabling accurate screening for tapeworm infections in companion animals.
In March 2026, Zoetis entered into a definitive agreement to acquire the global animal genomics business from Neogen(R) Corporation, incorporating specialized genomic sequencing and diagnostic reference workflows into its precision animal health portfolio.
In March 2026, Neogen announced the strategic sale and divestiture of its global animal genomics business unit to Zoetis Inc., reallocating capital to focus on its core food safety and sanitation testing product lines.
In January 2026, Antech launched RapidRead(TM) Dental for Feline, an AI-driven dental radiology interpretation tool built for cats, and integrated Symmetric Dimethylarginine (SDMA) kidney function biomarker testing onto its in-house Element i+ diagnostic platform at VMX 2026.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.